Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03967158 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluation of Effectiveness and Safety of XIENCE Sierra in Routine Clinical Practice

Study acronym: IRIS Sierra
StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fieldsv8
  2. Primary completion date changed from estimate of Jul 1, 2024 to Aug 27, 2024
    • Eligibility criteria expanded, about 2 words
    v7
  3. Primary completion date: Jul 1, 2023 to Jul 1, 2024
    • Trial status: Recruiting to Active, Not Recruiting
    • Study sites: 11 to 10
    v6
  4. Primary completion date: Jul 1, 2022 to Jul 1, 2023
    • Study sites: 12 to 11
    • Study completion date: Dec 31, 2027 to Dec 31, 2028
    v5
  5. Secondary endpoints: 9 to 10v4
Show 2 earlier versionsHide 2 earlier versions
  1. Primary completion date: Jul 1, 2021 to Jul 1, 2022
    • Study sites: 11 to 12
    • Study completion date: Dec 31, 2026 to Dec 31, 2027
    v3
  2. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Jul 1, 2019 to Dec 23, 2019
    • Study sites: 1 to 11
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The objective of this study is to evaluate effectiveness and safety of Xience Sierra stent in the "real world" daily practice as compared with other drug-eluting stents.
Trial Details
NCT Number NCT03967158
Lead Sponsor Seung-Jung Park
Collaborators: CardioVascular Research Foundation, Korea
Conditions
(from sponsor)		 Coronary Artery Disease, Coronary Disease
Related terms Coronary Artery Disease, Coronary Disease
Enrollment 2,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov